Viking Therapeutics Takeover Target in Biotech Investing?
Investors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
Common triggers like income changes or new expenses alert you to reallocate funds in your budget.
17,780 articlesInvestors increasingly ask whether Viking Therapeutics could become a takeover target. This article breaks down why b...
A policy showdown in Washington threatens to pull border guards from airports in sanctuary cities, risking flight dis...
NVIDIA has redefined its role in the AI era, but the upside isn’t finished. This piece unpack three practical reasons...
Investors are watching Modine for clues on growth in HVAC and thermal solutions. This guide breaks down the modine (m...
Glamsterdam targets a mid-2026 mainnet upgrade that aims to ease congestion and boost Ethereum’s throughput. Analysts...
Are you wondering if buying USA Rare Earth stock could lead to a million-dollar outcome? This guide breaks down the r...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
As PDD Holdings gears up for its (pdd) 2026 earnings call, investors should focus on growth sustainability, margin pr...
Applovin rallied today as traders weighed an upbeat analyst note against a quiet news cycle. This piece breaks down t...
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...
Intuitive Machines led a mixed day in space stocks, rising about 9% as rivals eased back in a rotation-focused market...
Palantir faces a steeper path in 2026 as the stock retreats, yet bulls argue the core AI platform and government dema...